13/11/2013
Fidia Pharma USA Inc to exhibit at AAOS Annual Meeting 2014
Fidia Pharma USA, Inc. will be exhibiting at the Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS) in New Orleans, LA, March 11-15, 2014.
Please come and see us at booth 973.
We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee).
HYALGAN® is a treatment option for people who do not get adequate pain relief from simple painkillers (like Tylenol® or Advil®) or from exercise and physical therapy. HYALGAN® injections can be used in addition to prescription pain relievers (like Celebrex®).
Please come and see us at booth 973.
We will be exhibiting our flagship product HYALGAN® (sodium hyaluronate, intra-articular injections for the treatment of pain in osteoarthritis of the knee).
HYALGAN® is a treatment option for people who do not get adequate pain relief from simple painkillers (like Tylenol® or Advil®) or from exercise and physical therapy. HYALGAN® injections can be used in addition to prescription pain relievers (like Celebrex®).
